Clinical Trials Logo

Fibrosis clinical trials

View clinical trials related to Fibrosis.

Filter by:

NCT ID: NCT02937935 Not yet recruiting - Clinical trials for Acute Kidney Injury With Cirrhosis

On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Intervention: All patients at presentation would be assessed for the underlying cause of and will be managed by removal of all precipitants(careful review of medications, diuretics, nephrotoxic drugs,vasodilators or non-steroidal anti-inflammatory drugs). The second step would be to consider plasma volume expansion in patients with hypovolemia (the choice of fluid could either be a crystalloid or albumin or even blood as indicated) along with identification and early treatment of bacterial infections. Along with this patients with a differential diagnosis of HRS-AKI would be given terlipressin ( or noradrenaline/octreotide midodrine in case of contraindication to terlipressin). Patients with a clinical diagnosis of ATN would be randomized to the on-demand versus protocol-guided dialysis groups. Further, patients with urine output of less than 0.5ml/kg/hour for 4-6 hours despite adequate fluid resuscitation and vasoconstrictors would also be subjected to randomization. 1. In the on-demand group patients would get dialysis only when patient fulfills absolute criteria requiring dialysis such as metabolic acidosis with ph<7.2, hyperkalemia, refractory fluid overload (non-responsive to diuretics) or oliguria with urine output of less than 0.5ml/kg for more than 24-48 hours from the time of randomization 2. In the protocol guided group patients all patients would be considered for dialysis within 6 hours of randomization After randomization patients would receive dialysis as three sessions per week of at least 4 h with a blood flow >200 mL/min and a dialysate flow >500 mL/min in intermittent group and as 20-25 mL/kg/h of effluent, by filtration and/or diffusion in continuous form until recovery of renal functions

NCT ID: NCT02898376 Not yet recruiting - Breast Carcinoma Clinical Trials

Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer

FIBROTHERME
Start date: December 2018
Phase: Phase 3
Study type: Interventional

This study evaluates the dermatological life quality six months after spa cares in patients with severe late toxicity involving the skin and / or soft tissues after postoperative radiotherapy for breast cancer. Half of the patients will be treated with a combination of pentoxifylline (PTX) and alpha-tocopherol (Vit E) when Half of the patients will receive skin-oriented spa cares in addition.

NCT ID: NCT02885961 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

Start date: August 2016
Phase: N/A
Study type: Interventional

The pathogenesis of idiopathic pulmonary fibrosis (IPF) is incompletely understood but recurrent epithelial injury occurs which evokes the coagulation cascade. Thrombin is produced as a result and is over expressed in IPF patients, so may be important in propagating disease activity. We aim to recruit patients with IPF and then complete FDG (18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose) PET (positron emission tomography) scans pre and post manipulation of the coagulation cascade to assess the role of this biological pathway in disease activity. Previous studies from our institution have demonstrated increased FDG avidity in the lungs of patients with IPF (assessed using FDG PET scans) but to date the cells and pathways responsible for this signal have not been identified and thus need further exploration.

NCT ID: NCT02865369 Not yet recruiting - Chronic Hepatitis C Clinical Trials

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

RELIF-C
Start date: September 2016
Phase: N/A
Study type: Observational [Patient Registry]

A study on regression of liver fibrosis assessed by transient elastography after Daclatasvir and Asunaprevir combined treatment in advanced fibrotic/cirrhotic patients with chronic hepatitis C genotype 1b Infection

NCT ID: NCT02848625 Not yet recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis

Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis

YES-IPF
Start date: August 2016
Phase: N/A
Study type: Interventional

This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. After the first group completes 12 weeks of yoga, the patients who were randomized to usual care will completed 12 weeks of yoga.

NCT ID: NCT02753374 Not yet recruiting - Cystic Fibrosis Clinical Trials

Registry Study on Cystic Fibrosis in Chinese Children

Start date: May 2016
Phase: N/A
Study type: Observational

This study is a multicenter, prospective cohort study of patients diagnosed with cystic fibrosis, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.

NCT ID: NCT02710227 Not yet recruiting - Liver Cirrhosis Clinical Trials

Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis

Start date: September 2018
Phase: N/A
Study type: Observational

Individuals with hepatic cirrhosis (n=50) and healthy controls (n=30) were recruited. Sleep quality, sleep timing parameters and circadian preference were evaluated using the Pittsburgh Sleep Quality Index (PSQI), Sleep Timing Questionnaire (STQ) and The Composite Scale for Morningness (CSM) respectively

NCT ID: NCT02642861 Not yet recruiting - Liver Cirrhosis Clinical Trials

Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis

Start date: October 2018
Phase: Phase 3
Study type: Interventional

- Cyclobenzaprine, is a muscle relaxer medication used to relieve skeletal muscle spasms. It is one of the best-studied drug for this application.

NCT ID: NCT02642484 Not yet recruiting - Liver Cirrhosis Clinical Trials

Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis

Start date: December 2018
Phase: Phase 3
Study type: Interventional

- Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. - Quinine was suggested for treatment of patients with muscle cramps in patients with liver cirrhosis. However, thrombocytopenia, cardiac arrhythmias and cinchonism are serious side effects.

NCT ID: NCT02591524 Not yet recruiting - Cystic Fibrosis Clinical Trials

Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation

Start date: November 2015
Phase: N/A
Study type: Interventional

A hot topic in lung transplantation is the treatment of persisting sinus disease/colonization in CF patients to prevent descending graft colonization and chronic allograft dysfunction. From 2012, the Hannover transplantation group has been using a conservative approach with topical nasal inhalation. It is now necessary to analyse the impact of the new approach on graft colonization, incidence of BOS, symptoms, QoL etc in comparison to a historical cohort. It is also important to establish which is the best among the different inhaled antibiotic regimens currently available.